- Home
- CRGX vs GASS Comparison
CRGX vs GASS Comparison
Compare CRGX & GASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- GASS
- Stock Information
- Founded
- CRGX 2021
- GASS 2004
- Country
- CRGX United States
- GASS Greece
- Employees
- CRGX N/A
- GASS N/A
- Industry
- CRGX
- GASS Marine Transportation
- Sector
- CRGX
- GASS Consumer Discretionary
- Exchange
- CRGX Nasdaq
- GASS Nasdaq
- Market Cap
- CRGX 213.5M
- GASS 224.5M
- IPO Year
- CRGX 2023
- GASS 2005
- Fundamental
- Price
- CRGX $4.52
- GASS $6.72
- Analyst Decision
- CRGX Hold
- GASS
- Analyst Count
- CRGX 7
- GASS 0
- Target Price
- CRGX $5.33
- GASS N/A
- AVG Volume (30 Days)
- CRGX 3.0M
- GASS 74.9K
- Earning Date
- CRGX 08-11-2025
- GASS 09-04-2025
- Dividend Yield
- CRGX N/A
- GASS N/A
- EPS Growth
- CRGX N/A
- GASS 27.26
- EPS
- CRGX N/A
- GASS 1.80
- Revenue
- CRGX N/A
- GASS $167,724,264.00
- Revenue This Year
- CRGX $57.81
- GASS $2.94
- Revenue Next Year
- CRGX N/A
- GASS $3.49
- P/E Ratio
- CRGX N/A
- GASS $3.72
- Revenue Growth
- CRGX N/A
- GASS 14.07
- 52 Week Low
- CRGX $3.00
- GASS $4.82
- 52 Week High
- CRGX $25.45
- GASS $7.26
- Technical
- Relative Strength Index (RSI)
- CRGX 54.72
- GASS 56.98
- Support Level
- CRGX $4.40
- GASS $6.46
- Resistance Level
- CRGX $4.63
- GASS $6.83
- Average True Range (ATR)
- CRGX 0.07
- GASS 0.15
- MACD
- CRGX -0.01
- GASS -0.01
- Stochastic Oscillator
- CRGX 34.29
- GASS 73.81
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
About GASS StealthGas Inc.
StealthGas Inc is an international shipping transportation company. It owns liquefied petroleum gas (LPG) pressurized carriers and provides international seaborne transportation services to LPG producers and users, as well as crude oil and product carriers to oil producers, refineries, and commodities traders. The company carriers carry various petroleum gas products in liquefied forms, such as propane, butane, butadiene, isopropane, propylene, and vinyl chloride monomer, which are all byproducts of the production of crude oil and natural gas.